IPRMT1

IPRMT1 is an effective and selective PRMT1 inhibitor useful for breast cancer research. It inhibits the growth of breast cancer cells both in vitro and in vivo, with EC50 values of 90 nM, 70 nM, and 9 nM for MCF7, T47D, and MDA-MB-231 cell lines, respectively.